Neoleukin Therapeutics Quote - NLTX | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Neoleukin Therapeutics Inc (NLTX) Share Price

Neoleukin Therapeutics Inc (NLTX)

3.49

0.00

(0.00%)

Closed 12 December 8:00AM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

3.49

Bid

3.42

Offer

3.56

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

3.49

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

11,663,000

Dividend Yield

-

PE Ratio

-7.45

Earnings Per Share (EPS)

-3.11

Revenue

-

Net Profit

-36.32M

Neoleukin Therapeutics Inc operates as a biopharmaceutical company. The firm generates immunotherapies using de novo protein design technology. It uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit o... Neoleukin Therapeutics Inc operates as a biopharmaceutical company. The firm generates immunotherapies using de novo protein design technology. It uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its product line comprises NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.neoleukin.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LAESSEALSQ Corporation	US$ 1.1406 (99.75%)	225.46M
AMPGAmplitech Group Inc	US$ 1.9001 (91.52%)	201.88M
CADLCandel Therapeutics Inc	US$ 7.7401 (67.90%)	100.61M
JZXNJiuzi Holdings Inc	US$ 1.792 (60.00%)	2.56M
LDTCLeddarTech Holdings Inc	US$ 1.81 (49.59%)	75.14M
SFHGSamfine Creation Holdings Group Ltd	US$ 3.04 (-85.59%)	10.2M
CLRBCellectar Biosciences Inc	US$ 0.3039 (-76.26%)	37.51M
QTTBQ32 Bio Inc	US$ 6.0291 (-75.30%)	3.39M
TFFPTFF Pharmaceuticals Inc	US$ 0.1639 (-45.78%)	3.5M
MARXMars Acquisition Corporation	US$ 7.24 (-33.33%)	54.57k
RGTIRigetti Computing Inc	US$ 7.38 (13.71%)	307.29M
LAESSEALSQ Corporation	US$ 1.1406 (99.75%)	223.51M
AMPGAmplitech Group Inc	US$ 1.9001 (91.52%)	200.45M
NVDANVIDIA Corporation	US$ 139.31 (3.14%)	182.44M
LCIDLucid Group Inc	US$ 2.44 (3.39%)	110.58M

mick

mick 11 months ago

https://www.otcmarkets.com/stock/NLTX

mick

mick 12 months ago

https://www.otcmarkets.com/stock/N,TX

mick

mick 1 year ago

https://www.otcmarkets.com/stock/NLTX

mick

mick 1 year ago

https://www.otcmarkets.com/stock/NLTX

mick

mick 1 year ago

https://www.otcmarkets.com/stock/NLTX

mick

mick 1 year ago

NLTX
Neoleukin Therapeutics Inc
0.62
-0.012 (-1.90%)
Volume: 41,286
Day Range: 0.61 - 0.6399
Last Trade Time: 4:00:00 PM EDT

AJ Freely

AJ Freely 1 year ago

$NLTX -Announce Definitive Merger Agreement with Neoleukin | 7/19/23
Combined company to have $200m in cash
To close Q4 '23
Up 6.4% Pre-Market/ Current Price $0.72

tw0122

tw0122 1 year ago

Neurogene and Neoleukin Announce Definitive Merger Agreement

Source: GlobeNewswire Inc.

Neurogene Inc., a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, and Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) today announced that they have entered into a definitive

mick

mick 1 year ago

NLTX
Neoleukin Therapeutics Inc
0.84
0.0039 (0.47%)
Volume: 41,492
Day Range: 0.815 - 0.847
Last Trade Time: 4:40:38 PM EDT

mick

mick 1 year ago

NLTX
Neoleukin Therapeutics Inc
0.771
0.0109 (1.43%)
Volume: 103,148
Day Range: 0.750101 - 0.8106
Last Trade Time: 5:42:29 PM EDT

mick

mick 1 year ago

NLTX
Neoleukin Therapeutics Inc
0.771
0.0109 (1.43%)
Volume: 103,148
Day Range: 0.750101 - 0.8106
Last Trade Time: 5:42:29 PM EDT

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
0.82
0.01 (1.23%)
Volume: 34,560
Day Range: 0.81 - 0.83
Last Trade Time: 4:40:59 PM EDT

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
0.8948
0.0217 (2.49%)
Volume: 196,980
Day Range: 0.8599 - 0.8944
Last Trade Time: 7:52:42 PM EDT

mick

mick 2 years ago

52WK RANGE 0.38 - 1.56

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
0.79
0.0072 (0.92%)
Volume: 161,187
Day Range: 0.7723 - 0.7943
Last Trade Time: 5:10:01 PM EDT

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
0.5104
-0.0395 (-7.18%)
Volume: 43,495
Day Range: 0.503 - 0.537501
Last Trade Time: 4:00:00 PM EST

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
0.517
-0.01315 (-2.48%)
Volume: 102,340
Day Range: 0.501 - 0.5399
Last Trade Time: 4:08:16 PM EST

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
0.60
0.0217 (3.75%)
Volume: 160,071
Day Range: 0.5801 - 0.633179
Last Trade Time: 4:36:19 PM EST

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
0.4498
-0.0028 (-0.62%)
Volume: 4,377,094
Day Range: 0.433 - 0.50
Last Trade Time: 7:41:01 PM EST

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
0.6301
0.0601 (10.54%)
Volume: 139,333
Day Range: 0.57 - 0.643599
Bid: 0.4974
Ask: 0.761
Last Trade Time: 7:14:10 PM EDT
Total Trades: 429
NLTX Detailed Quote

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
1.03
-0.03 (-2.83%)
Volume: 113,175
Day Range: 1.00 - 1.06
Bid: 1.01
Ask: 1.08
Last Trade Time: 4:02:39 PM EDT
Total Trades: 424
NLTX Detailed Quote

mick

mick 2 years ago

NLTX
Neoleukin Therapeutics Inc
1.08
0.04 (3.85%)
Volume: 70,878
Day Range: 1.02 - 1.10
Bid: 0.98
Ask: 1.14
Last Trade Time: 4:00:00 PM EDT
Total Trades: 544
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
0.9943 ? 0.079 (8.63%)
Volume: 176,727 @06/03/22 6:10:35 PM EDT
Bid Ask Day's Range
0.89 0.9899 0.9 - 0.9799
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeutics Announces Preclinical Data for NL-201 at American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/13/2022 02:00:00 PM
Mizuho Securities Sticks to Their Buy Rating for Neoleukin Therapeutics (NLTX) • TipRanks • 04/11/2022 02:25:10 AM

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
1.22 ? -0.02 (-1.61%)
Volume: 405,223 @04/29/22 4:00:48 PM EDT
Bid Ask Day's Range
1.18 1.33 1.21 - 1.36
NLTX Detailed Quote

crudeoil24

crudeoil24 3 years ago

Neoleukin Therapeutics Is Maintained at Overweight by Piper Sandler

crudeoil24

crudeoil24 3 years ago

NLTX moving up before ACCR > Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced three presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting taking place April 8-13, 2022 in New Orleans, Louisiana.

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
2.13 ? -0.23 (-9.75%)
Volume: 143,302 @03/11/22 5:50:15 PM EST
Bid Ask Day's Range
2.0 2.14 2.12 - 2.43
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
3.28 ? 0.11 (3.47%)
Volume: 230,741 @02/04/22 4:00:57 PM EST
Bid Ask Day's Range
2.68 3.29 3.1 - 3.32
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
4.85 ? -0.38 (-7.27%)
Volume: 216,000 @01/04/22 7:38:36 PM EST
Bid Ask Day's Range
4.0 4.85 4.81 - 5.35
NLTX Detailed Quote

mick

mick 3 years ago

thank you good repore' $nltx

Phosphene

Phosphene 3 years ago

https://www.geekwire.com/2021/biosensor-startup-monod-lands-6m-and-spins-out-of-univ-of-washingtons-institute-for-protein-design/

NLTX Co-founder and Head of research recently founded Monod Bio.

December 23, 2021.

mick

mick 3 years ago

https://www.otcmarkets.com/stock/NLTX

mick

mick 3 years ago

https://www.otcmarkets.com/stock/NLTX

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
7.69 ? 0.25 (3.36%)
Volume: 172,375 @11/05/21 5:30:12 PM EDT
Bid Ask Day's Range
7.75 8.41 7.25 - 7.9
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
6.63 ? -0.07 (-1.04%)
Volume: 3,590 @10/08/21 10:49:01 AM EDT
Bid Ask Day's Range
6.6 6.65 6.61 - 6.74
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
7.53 ? 0.0 (0.00%)
Volume: 67,454 @09/22/21 4:02:00 PM EDT
Bid Ask Day's Range
7.0 8.4 7.44 - 7.84
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
6.81 ? -0.18 (-2.58%)
Volume: 114,939 @08/13/21 4:00:54 PM EDT
Bid Ask Day's Range
6.5 8.0 6.75 - 7.15
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
9.21 ? 0.32 (3.60%)
Volume: 54,372 @07/09/21 4:00:59 PM EDT
Bid Ask Day's Range
8.19 10.0 8.84 - 9.25
NLTX Detailed Quote

mick

mick 3 years ago

Neoleukin Therapeuti (NLTX)
8.89 ? -0.17 (-1.88%)
Volume: 107,040 @07/08/21 1:52:12 PM EDT
Bid Ask Day's Range
8.87 8.9 8.7 - 8.99
NLTX Detailed Quote

mick

mick 4 years ago

Neoleukin Therapeuti (NLTX)
9.9481 ? 0.0781 (0.79%)
Volume: 74,185 @05/26/21 11:28:02 AM EDT
Bid Ask Day's Range
9.9 9.98 9.83 - 10.21
NLTX Detailed Quote

mick

mick 4 years ago

mick

mick 4 years ago

mick

mick 4 years ago

Neoleukin Therapeuti (NLTX)
11.96 ? -0.24 (-1.97%)
Volume: 121,326 @04/16/21 5:03:06 PM EDT
Bid Ask Day's Range
11.2 15.0 11.77 - 12.345
NLTX Detailed Quote

mick

mick 4 years ago

Neoleukin Therapeuti (NLTX)
13.2 ? 0.41 (3.21%)
Volume: 158,178 @02/19/21 4:30:31 PM EST
Bid Ask Day's Range
11.11 14.05 12.83 - 13.5399
NLTX Detailed Quote

mick

mick 4 years ago

https://otcbb.swingtradebot.com/equities/NLTX

N.Y. , NASDAQ
https://swingtradebot.com/equities/NLTX

mick

mick 4 years ago

Schrogtergracht

Schrogtergracht 4 years ago

Well, since you're asking... erm... a few thousand points of the Dow, S&P and Nasdaq, maybe, if it isn't too much trouble? THX!

P.S. After the weekend is ok too, in case you're busy. Fridays and stuff.

mick

mick 4 years ago

thank you, any other business ?????

Schrogtergracht

Schrogtergracht 4 years ago

Thanks for trying, mick. P.S. The all caps had me laughing out loud. Cheers.
(This one is better of in the bin too as it was just to let you know no hard feelings here.)

Neoleukin Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions